Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy

SIMPLE SUMMARY: Since neuroaxonal damage and loss are observed in chemotherapy-induced peripheral neuropathy (CIPN) and results in permanent disability, detecting and monitoring neuropathy with a serum biomarker would be advantageous in identifying the development, severity, and resolution of CIPN....

Descripción completa

Detalles Bibliográficos
Autores principales: Cavaletti, Guido, Pizzamiglio, Chiara, Man, Albert, Engber, Thomas M., Comi, Cristoforo, Wilbraham, Darren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486738/
https://www.ncbi.nlm.nih.gov/pubmed/37686492
http://dx.doi.org/10.3390/cancers15174216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486738/
https://www.ncbi.nlm.nih.gov/pubmed/37686492
http://dx.doi.org/10.3390/cancers15174216

Ejemplares similares